Bollant Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-05-2024
- Paid Up Capital ₹ 0.10 M
as on 27-05-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Bollant Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srikanth Bolla, Swarnalatha Thakkillapati, Nandyala Narasamma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299TG2020PTC145709
- Company No.
145709
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bollant Laboratories Private Limited offer?
Bollant Laboratories Private Limited offers a wide range of products and services, including Paper & Paper Made Products, Laminated Paper.
Who are the key members and board of directors at Bollant Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swarnalatha Thakkillapati  | Director | Current | |
| Srikanth Bolla | Director | 07-Nov-2020 | Current |
| Nandyala Narasamma | Additional Director | 19-Aug-2022 | Current |
| Sirisha Rajulapati | Director | 28-Mar-2023 | Current |
Financial Performance of Bollant Laboratories.
Enhance accessibility to Bollant Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bollant Laboratories?
Unlock access to Bollant Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Bollant Packagings Private LimitedActive 6 years 5 months
Srikanth Bolla and Swarnalatha Thakkillapati are mutual person
- Bollant Logistics Private LimitedActive 6 years 5 months
Srikanth Bolla, Swarnalatha Thakkillapati and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bollant Laboratories?
Bollant Laboratories has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bollant Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bollant Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
